Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
The Journal of Biological Chemistry
|
October 26, 2016
A Critical Role for β-Catenin in Modulating Levels of Insulin Secretion from β-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization
Brie Sorrenson, Emmanuelle Cognard, Kathryn L Lee, et al.
Bioscience Reports
|
October 2, 2020
Prolonged treatment with a PI3K p110α inhibitor causes sex- and tissue-dependent changes in antioxidant content, but does not affect mitochondrial function
Christopher P Hedges, Toan Pham, Bhoopika Shetty, et al.
Clinical Science (London, England : 1979)
|
December 7, 2011
DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular
Christina M Buchanan, Jen-Hsing Shih, Jonathan W Astin, et al.
The Journal of Biological Chemistry
|
May 5, 2004
Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism
Li Li, Line M Grønning, Per O Anderson, et al.
Journal of Cellular Physiology
|
October 22, 2011
The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle
Qi Ge, Lyn M Moir, Thomas Trian, et al.
The Biochemical Journal
|
March 12, 2016
Niclosamide blocks glucagon phosphorylation of Ser552 on β-catenin in primary rat hepatocytes via PKA signalling
Md Kamrul H Chowdhury, Lindsay E Wu, James L J Coleman, et al.
FEBS Letters
|
December 29, 2004
Phosphorylation of glycosyl-phosphatidylinositol by phosphatidylinositol 3-kinase changes its properties as a substrate for phospholipases
David R Jones, Covadonga Pañeda, Ana Victoria Villar, et al.
International Journal of Obesity (2005)
|
March 31, 2019
The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice
Troy L Merry, Anna E S Brooks, Stewart W Masson, et al.
The Journal of Biological Chemistry
|
July 24, 2007
The role of phosphoinositide 3-kinase C2alpha in insulin signaling
Marco Falasca, William E Hughes, Veronica Dominguez, et al.
The Biochemical Journal
|
April 17, 2012
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis
Zhaohua Zheng, Syazwani I Amran, Jiuxiang Zhu, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
The Journal of Biological Chemistry
|
October 26, 2016
A Critical Role for β-Catenin in Modulating Levels of Insulin Secretion from β-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization
Brie Sorrenson, Emmanuelle Cognard, Kathryn L Lee, et al.
Bioscience Reports
|
October 2, 2020
Prolonged treatment with a PI3K p110α inhibitor causes sex- and tissue-dependent changes in antioxidant content, but does not affect mitochondrial function
Christopher P Hedges, Toan Pham, Bhoopika Shetty, et al.
Clinical Science (London, England : 1979)
|
December 7, 2011
DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular
Christina M Buchanan, Jen-Hsing Shih, Jonathan W Astin, et al.
The Journal of Biological Chemistry
|
May 5, 2004
Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism
Li Li, Line M Grønning, Per O Anderson, et al.
Journal of Cellular Physiology
|
October 22, 2011
The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle
Qi Ge, Lyn M Moir, Thomas Trian, et al.
The Biochemical Journal
|
March 12, 2016
Niclosamide blocks glucagon phosphorylation of Ser552 on β-catenin in primary rat hepatocytes via PKA signalling
Md Kamrul H Chowdhury, Lindsay E Wu, James L J Coleman, et al.
FEBS Letters
|
December 29, 2004
Phosphorylation of glycosyl-phosphatidylinositol by phosphatidylinositol 3-kinase changes its properties as a substrate for phospholipases
David R Jones, Covadonga Pañeda, Ana Victoria Villar, et al.
International Journal of Obesity (2005)
|
March 31, 2019
The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice
Troy L Merry, Anna E S Brooks, Stewart W Masson, et al.
The Journal of Biological Chemistry
|
July 24, 2007
The role of phosphoinositide 3-kinase C2alpha in insulin signaling
Marco Falasca, William E Hughes, Veronica Dominguez, et al.
The Biochemical Journal
|
April 17, 2012
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis
Zhaohua Zheng, Syazwani I Amran, Jiuxiang Zhu, et al.
Page
of 11